286 related articles for article (PubMed ID: 27252423)
1. Perivascular Cells in Diffuse Cutaneous Systemic Sclerosis Overexpress Activated ADAM12 and Are Involved in Myofibroblast Transdifferentiation and Development of Fibrosis.
Cipriani P; Di Benedetto P; Ruscitti P; Liakouli V; Berardicurti O; Carubbi F; Ciccia F; Guggino G; Zazzeroni F; Alesse E; Triolo G; Giacomelli R
J Rheumatol; 2016 Jul; 43(7):1340-9. PubMed ID: 27252423
[TBL] [Abstract][Full Text] [Related]
2. Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy.
Di Benedetto P; Liakouli V; Ruscitti P; Berardicurti O; Carubbi F; Panzera N; Di Bartolomeo S; Guggino G; Ciccia F; Triolo G; Cipriani P; Giacomelli R
Arthritis Res Ther; 2018 Oct; 20(1):223. PubMed ID: 30285896
[TBL] [Abstract][Full Text] [Related]
3. Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis.
Rajkumar VS; Howell K; Csiszar K; Denton CP; Black CM; Abraham DJ
Arthritis Res Ther; 2005; 7(5):R1113-23. PubMed ID: 16207328
[TBL] [Abstract][Full Text] [Related]
4. [Transdifferentiation of fibroblasts into myofibroblasts in the skin lesion of systemic sclerosis: role of transforming growth factor β1 and its signal transduction].
Liu T; Hu XD
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1840-5. PubMed ID: 22126761
[TBL] [Abstract][Full Text] [Related]
5. Impaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: a link between vascular and fibrotic features.
Cipriani P; Di Benedetto P; Ruscitti P; Campese AF; Liakouli V; Carubbi F; Pantano I; Berardicurt O; Screpanti I; Giacomelli R
Arthritis Res Ther; 2014 Sep; 16(5):442. PubMed ID: 25248297
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of ephrins and thrombospondins in the dermis of patients with early diffuse systemic sclerosis: potential contribution to perturbed angiogenesis and fibrosis.
Avouac J; Clemessy M; Distler JH; Gasc JM; Ruiz B; Vacher-Lavenu MC; Wipff J; Kahan A; Boileau C; Corvol P; Allanore Y
Rheumatology (Oxford); 2011 Aug; 50(8):1494-504. PubMed ID: 21454305
[TBL] [Abstract][Full Text] [Related]
7. [Role of PDGF-A/PDGFR-α in proliferation and transdifferentiation of fibroblasts from skin lesions of patients with systemic sclerosis].
Liu T; Zhang J
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Apr; 32(4):496-501. PubMed ID: 22543129
[TBL] [Abstract][Full Text] [Related]
8. Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation.
Carulli MT; Ong VH; Ponticos M; Shiwen X; Abraham DJ; Black CM; Denton CP
Arthritis Rheum; 2005 Dec; 52(12):3772-82. PubMed ID: 16320328
[TBL] [Abstract][Full Text] [Related]
9. Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study.
Corallo C; Cutolo M; Kahaleh B; Pecetti G; Montella A; Chirico C; Soldano S; Nuti R; Giordano N
Arthritis Res Ther; 2016 Oct; 18(1):228. PubMed ID: 27716320
[TBL] [Abstract][Full Text] [Related]
10. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
McCoy SS; Reed TJ; Berthier CC; Tsou PS; Liu J; Gudjonsson JE; Khanna D; Kahlenberg JM
Rheumatology (Oxford); 2017 Nov; 56(11):1970-1981. PubMed ID: 28968684
[TBL] [Abstract][Full Text] [Related]
11. The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist.
Cipriani P; Di Benedetto P; Ruscitti P; Capece D; Zazzeroni F; Liakouli V; Pantano I; Berardicurti O; Carubbi F; Pecetti G; Turricchia S; Alesse E; Iglarz M; Giacomelli R
J Rheumatol; 2015 Oct; 42(10):1808-16. PubMed ID: 26276964
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous inhibition of c-Abl and Src kinases abrogates the exaggerated expression of profibrotic genes in cultured systemic sclerosis dermal fibroblasts.
Piera-Velazquez S; Jimenez SA
Clin Exp Rheumatol; 2018; 36 Suppl 113(4):36-44. PubMed ID: 30277861
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of RXFP1 receptor contributes to the inefficacy of relaxin-based anti-fibrotic treatments in systemic sclerosis.
Corallo C; Pinto AM; Renieri A; Cheleschi S; Fioravanti A; Cutolo M; Soldano S; Nuti R; Giordano N
Clin Exp Rheumatol; 2019; 37 Suppl 119(4):69-75. PubMed ID: 31365333
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.
Guiducci S; Manetti M; Romano E; Mazzanti B; Ceccarelli C; Dal Pozzo S; Milia AF; Bellando-Randone S; Fiori G; Conforti ML; Saccardi R; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2011 Nov; 70(11):2011-21. PubMed ID: 21821866
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of ADAM12-S: possible association with the initiation and progression of dermal fibrosis and interstitial lung disease in patients with systemic sclerosis.
Taniguchi T; Asano Y; Akamata K; Aozasa N; Noda S; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):747-53. PubMed ID: 22540429
[TBL] [Abstract][Full Text] [Related]
16. Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts.
Cipriani P; Di Benedetto P; Ruscitti P; Verzella D; Fischietti M; Zazzeroni F; Liakouli V; Carubbi F; Berardicurti O; Alesse E; Giacomelli R
Arthritis Res Ther; 2015 Sep; 17(1):247. PubMed ID: 26357964
[TBL] [Abstract][Full Text] [Related]
17. Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine.
Cipriani P; Marrelli A; Benedetto PD; Liakouli V; Carubbi F; Ruscitti P; Alvaro S; Pantano I; Campese AF; Grazioli P; Screpanti I; Giacomelli R
Angiogenesis; 2013 Jul; 16(3):595-607. PubMed ID: 23413114
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic Activation of Mesenchymal Stem Cells Is Induced by the Disease Microenvironment in Systemic Sclerosis.
Taki Z; Gostjeva E; Thilly W; Yaseen B; Lopez H; Mirza M; Hassuji Z; Vigneswaran S; Ahmed Abdi B; Hart A; Arumalla N; Thomas G; Denton CP; Suleman Y; Liu H; Venturini C; O'Reilly S; Xu S; Stratton R
Arthritis Rheumatol; 2020 Aug; 72(8):1361-1374. PubMed ID: 32237059
[TBL] [Abstract][Full Text] [Related]
19. Thymic stromal lymphopoietin is up-regulated in the skin of patients with systemic sclerosis and induces profibrotic genes and intracellular signaling that overlap with those induced by interleukin-13 and transforming growth factor β.
Christmann RB; Mathes A; Affandi AJ; Padilla C; Nazari B; Bujor AM; Stifano G; Lafyatis R
Arthritis Rheum; 2013 May; 65(5):1335-46. PubMed ID: 23335246
[TBL] [Abstract][Full Text] [Related]
20. Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor beta.
Farina G; Lemaire R; Pancari P; Bayle J; Widom RL; Lafyatis R
Ann Rheum Dis; 2009 Mar; 68(3):435-41. PubMed ID: 18408251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
